UNRESECTABLE UROTHELIAL CARCINOMA

Clinical trials for UNRESECTABLE UROTHELIAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE UROTHELIAL CARCINOMA trials appear

Sign up with your email to follow new studies for UNRESECTABLE UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet finished but already full! 3 Terminated 1

Targeted attack: new combo therapy tested for tough bladder cancers

Disease control Terminated

This study aimed to see if a new drug combination (pemigatinib plus pembrolizumab) worked better than standard care for people with advanced bladder cancer who cannot take cisplatin and have a specific genetic change (FGFR3). It was a Phase 2 trial that was terminated early, enro…

Matched conditions: UNRESECTABLE UROTHELIAL CARCINOMA

Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

UNRESECTABLE UROTHELIAL CARCINOMA

Get alerted when new UNRESECTABLE UROTHELIAL CARCINOMA trials appear

Targeted attack: new combo therapy tested for tough bladder cancers